Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 13:19:56 UTC
Update Date2021-09-26 23:07:57 UTC
HMDB IDHMDB0254146
Secondary Accession NumbersNone
Metabolite Identification
Common NameLodoxamide
DescriptionLodoxamide, also known as alomide or lodoxamide ethyl, belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. It is marketed under the tradename Alomide in the UK. Like cromoglicic acid it acts as a mast cell stabilizer. In 2014 lodoxamide and bufrolin were found to be potent agonists at the G protein-coupled receptor 35, an orphan receptor believed to play a role in inflammatory processes, pain and the development of stomach cancer. Lodoxamide is an extremely weak basic (essentially neutral) compound (based on its pKa). Lodoxamide is an antiallergic pharmaceutical drug. This compound has been identified in human blood as reported by (PMID: 31557052 ). Lodoxamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Lodoxamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
AlomideKegg
Diethyl N,n'-(2-chloro-5-cyano-m-phenylene)dioxamateMeSH
Lodoxamide ethylMeSH
{[3-(carboxyformamido)-2-chloro-5-cyanophenyl]carbamoyl}formateGenerator
Chemical FormulaC11H6ClN3O6
Average Molecular Weight311.63
Monoisotopic Molecular Weight310.9945126
IUPAC Name{[3-(carboxyformamido)-2-chloro-5-cyanophenyl]carbamoyl}formic acid
Traditional Namelodoxamide
CAS Registry NumberNot Available
SMILES
OC(=O)C(=O)NC1=CC(=CC(NC(=O)C(O)=O)=C1Cl)C#N
InChI Identifier
InChI=1S/C11H6ClN3O6/c12-7-5(14-8(16)10(18)19)1-4(3-13)2-6(7)15-9(17)11(20)21/h1-2H,(H,14,16)(H,15,17)(H,18,19)(H,20,21)
InChI KeyRVGLGHVJXCETIO-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentAlpha amino acids and derivatives
Alternative Parents
Substituents
  • Alpha-amino acid or derivatives
  • Anilide
  • Benzonitrile
  • N-arylamide
  • Chlorobenzene
  • Halobenzene
  • Aryl chloride
  • Aryl halide
  • Monocyclic benzene moiety
  • Benzenoid
  • Dicarboxylic acid or derivatives
  • Secondary carboxylic acid amide
  • Carboxamide group
  • Carboxylic acid
  • Carbonitrile
  • Nitrile
  • Organochloride
  • Organonitrogen compound
  • Organic nitrogen compound
  • Organooxygen compound
  • Carbonyl group
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organohalogen compound
  • Organic oxygen compound
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP0.72ALOGPS
logP0.83ChemAxon
logS-3.9ALOGPS
pKa (Strongest Acidic)-6.7ChemAxon
pKa (Strongest Basic)0.73ChemAxon
Physiological Charge-2ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area156.59 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity69.9 m³·mol⁻¹ChemAxon
Polarizability26.52 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+162.73130932474
DeepCCS[M-H]-160.37330932474
DeepCCS[M-2H]-193.97330932474
DeepCCS[M+Na]+169.20130932474
AllCCS[M+H]+162.532859911
AllCCS[M+H-H2O]+159.432859911
AllCCS[M+NH4]+165.432859911
AllCCS[M+Na]+166.332859911
AllCCS[M-H]-160.432859911
AllCCS[M+Na-2H]-160.232859911
AllCCS[M+HCOO]-160.132859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
LodoxamideOC(=O)C(=O)NC1=CC(=CC(NC(=O)C(O)=O)=C1Cl)C#N3762.6Standard polar33892256
LodoxamideOC(=O)C(=O)NC1=CC(=CC(NC(=O)C(O)=O)=C1Cl)C#N2172.8Standard non polar33892256
LodoxamideOC(=O)C(=O)NC1=CC(=CC(NC(=O)C(O)=O)=C1Cl)C#N3025.2Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Lodoxamide,3TMS,isomer #1C[Si](C)(C)OC(=O)C(=O)NC1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C)[Si](C)(C)C)=C1Cl2715.7Semi standard non polar33892256
Lodoxamide,3TMS,isomer #1C[Si](C)(C)OC(=O)C(=O)NC1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C)[Si](C)(C)C)=C1Cl2583.0Standard non polar33892256
Lodoxamide,3TMS,isomer #1C[Si](C)(C)OC(=O)C(=O)NC1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C)[Si](C)(C)C)=C1Cl3834.0Standard polar33892256
Lodoxamide,3TMS,isomer #2C[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O)[Si](C)(C)C)=C1Cl)[Si](C)(C)C2608.5Semi standard non polar33892256
Lodoxamide,3TMS,isomer #2C[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O)[Si](C)(C)C)=C1Cl)[Si](C)(C)C2584.2Standard non polar33892256
Lodoxamide,3TMS,isomer #2C[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O)[Si](C)(C)C)=C1Cl)[Si](C)(C)C3682.2Standard polar33892256
Lodoxamide,4TMS,isomer #1C[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C)[Si](C)(C)C)=C1Cl)[Si](C)(C)C2637.8Semi standard non polar33892256
Lodoxamide,4TMS,isomer #1C[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C)[Si](C)(C)C)=C1Cl)[Si](C)(C)C2593.1Standard non polar33892256
Lodoxamide,4TMS,isomer #1C[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C)[Si](C)(C)C)=C1Cl)[Si](C)(C)C3353.8Standard polar33892256
Lodoxamide,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)C(=O)NC1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1Cl3430.0Semi standard non polar33892256
Lodoxamide,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)C(=O)NC1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1Cl3201.7Standard non polar33892256
Lodoxamide,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)C(=O)NC1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1Cl3886.5Standard polar33892256
Lodoxamide,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O)[Si](C)(C)C(C)(C)C)=C1Cl)[Si](C)(C)C(C)(C)C3332.3Semi standard non polar33892256
Lodoxamide,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O)[Si](C)(C)C(C)(C)C)=C1Cl)[Si](C)(C)C(C)(C)C3226.1Standard non polar33892256
Lodoxamide,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O)[Si](C)(C)C(C)(C)C)=C1Cl)[Si](C)(C)C(C)(C)C3776.9Standard polar33892256
Lodoxamide,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1Cl)[Si](C)(C)C(C)(C)C3507.8Semi standard non polar33892256
Lodoxamide,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1Cl)[Si](C)(C)C(C)(C)C3385.1Standard non polar33892256
Lodoxamide,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1Cl)[Si](C)(C)C(C)(C)C3625.8Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Lodoxamide GC-MS (Non-derivatized) - 70eV, Positivesplash10-0006-9381000000-89026fcdf0dbeae86f2f2021-09-24Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Lodoxamide GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Lodoxamide GC-MS (TMS_1_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Lodoxamide GC-MS (TMS_1_2) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Lodoxamide GC-MS (TMS_2_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Lodoxamide GC-MS (TMS_2_2) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Lodoxamide GC-MS (TMS_2_3) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Lodoxamide GC-MS (TMS_2_4) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Lodoxamide GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Lodoxamide GC-MS (TBDMS_1_2) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Lodoxamide GC-MS (TBDMS_2_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Lodoxamide GC-MS (TBDMS_2_2) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Lodoxamide GC-MS (TBDMS_2_3) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Lodoxamide GC-MS (TBDMS_2_4) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lodoxamide 10V, Positive-QTOFsplash10-03di-0019000000-c898c8550566f192349e2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lodoxamide 20V, Positive-QTOFsplash10-03xr-2089000000-21ac75e7499c8701f4322016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lodoxamide 40V, Positive-QTOFsplash10-00dl-6490000000-4876ae79df6c98fc52892016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lodoxamide 10V, Negative-QTOFsplash10-0a4i-1019000000-76594d6a809eef8750fc2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lodoxamide 20V, Negative-QTOFsplash10-0a4i-5069000000-4b022e277de6e3c246f52016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lodoxamide 40V, Negative-QTOFsplash10-0006-9010000000-a23fd7c2e129e6aad4222016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lodoxamide 10V, Positive-QTOFsplash10-03di-0029000000-f4c208cf9e3e785926b32021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lodoxamide 20V, Positive-QTOFsplash10-00xu-0491000000-fa4b34415c8eaf378b802021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lodoxamide 40V, Positive-QTOFsplash10-014i-0910000000-3dbe20b49441e13f83ea2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lodoxamide 10V, Negative-QTOFsplash10-01b9-0090000000-93f6e059a547d6fa5e0d2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lodoxamide 20V, Negative-QTOFsplash10-014i-0090000000-7e6186f9901dd5eaaf082021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lodoxamide 40V, Negative-QTOFsplash10-01bc-1490000000-8c6feceaf5e2524891202021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB06794
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkLodoxamide
METLIN IDNot Available
PubChem Compound44564
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]